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I~  Molecular epidemiology of Mycobacterium abscessus colonizing 
cystic fibrosis (CF) patients in Western Sweden 
B. J6nsson 1, M. Gilljam 2, A. Lindblad 2, A.E. Wold 1 , C. Welinder-Olsson 1 . 
1Department of Clinical Bacteriology, Gdteborg University, 2 West Swedish CF 
Centre, Gdteborg, Sweden 
M. abscessus is an emerging respiratory pathogen of CF patients and the third most 
common species isolated in all mycobacterial cultures processed in G6teborg. 
Aims; To investigate if transmission of 3,4. abscessus occurs between individuals 
in the CF population, and to determine if colonized patients harbor a single strain 
over time or pick up a succession of strains. 
Methods; 70 isolates were examined of which 50 derived from 14 CF patients. 
For comparison 4 patients with infected wounds contracted in Thailand 2004, 
4 patients with chronic lung infection and 6 patients where M. abscessus seemed 
to be a contaminant were included. Isolates were examined by pulsed-field gel 
electrophoresis (PFGE). 
Results; All patients with chronic 3,4. abscessus colonization in the airways had a 
single strain that persisted over time. We found a cluster of 5 patients (4 with CF) 
from Western Sweden with identical PFGE pattern using AseI. All other patients 
had strains with unique PFGE patterns. 4 of the 5 cluster strains were also identical 
using XbaI. Of the 4 patients with identical AseI and XbaI patterns, 2 were siblings 
with CF, suggesting that transmission could have occurred. Isolates interpreted 
as contaminants and isolates acquired in Thailand were smooth, while clinically 
relevant airway strains were mainly rough. Smooth and rough strains from the 
same patient had identical PFGE patterns. 
Conclusions; Our results indicate that most patients colonized by M. abscessus in
the airways have unique strains, deriving from the environment, and that the cluster 
strain is probably a common environmental strain. The clinical relevance of rough 
versus mooth phenotypes has to be further studied. 
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~ Mycobacterium chelonae infection in a CF patient 
L. Travan 1 , L. Calligaris 1, M. Busetti 2, F. Poli 1 . 1ped. Dep., 2 UCO Igiene, IRCCS, 
Burlo Garofolo, Trieste, Italy 
Prevalence of atypical Mycobacterial infections (NTM) in CF patients seems 
increased in the last years, probably due to better ability in isolating these bacteria 
and to the increase of average lifespan. Moreover it is difficult to distinguish between 
patients with mere colonization and those with infection, because of absence of a 
peculiar picture. However in patients with a slow but constant worsening in lung 
function and no answer to traditional therapy, we must think about Mycobacterial 
infections. Our patient is a 18 y girl presenting progressive physical deterioration, 
weight loss and loss of lung function. She presented respiratory infections with slow 
reaction to antibiotic treatment and slow normalization of inflammation i dexes. In 
a sputum was isolated an alcohol-acid resistant bacilla, identified previously as a 
Nocardia nd then as a atypical rapidly growing Mycobacterium (M. chelonae). The 
patient in the meantime, despite a proper therapy (clarithromicina and amikacin), 
presented clinical worsening. She had fever for 8 days with important desaturation; 
despite iv treatment with tobramycin and cefoxitin and per os clarithromicina and 
rifabutine, only after 15 days she was stably apyretic with a good saturation. 
Infection by M. chelonae seems to be more frequent in Mediterranean rea than in 
USA; however there are few reports about infections by NTM. In Europe prevalence 
is about 3 5% in CF patients, while in USA is about 12 14%. Actually, even if it 
is not yet an epidemiologically relevant problem in Italy, knowing the possibility of 
atypical Mycobacterial infections is fundamental for physicians dealing with CF; 
they must suspect his kind of disease when there is a progressive worsening of 
clinical condition in patients not responsive to conventional treatments. 
I •  Prevalence of nontuberculous mycobacteria infection in 
cystic fibrosis (CF) pediatric patients in Piedmont region of Italy 
A. Veljkovic, I. Baussano, M.R Forneris, I. Tardivo, M. Castello, L. Anfossi, 
E. Bignamini. Dep. of Pulmonology, Paediatric CF Unit, Turin, Italy 
Background: Patients with CF, because of the impairment of non-specific local 
immunity, are at a high risk for acute and chronic airway infections. Nontubercu- 
lous Mycobacteria (NTM) may cause chronic pulmonary diseases and nutritional 
disturbances, impair quality of life and reduce survival. 
Material and Methods: Children with CF, older than 6 years and able to 
spontaneously provide an adequate sputum sample, attending the Regional Referent 
Center for CF of Piemonte and Valle d'Aosta in Italy were included. Diagnosis was 
based on the sputum smear and culture of three samples while Mycobacteria species 
identification was based on the culture identification and the PCR method. 
We adopted the diagnosis criteria of the American Thoracic Society's (ATS) 
recommendations. 
The following characteristic of the children were considered: CFTR genotype, 
pancreatic function, microbiological status, airway function and nutritional status. 
Results: Among the 36 patients included in the study, 2 were positive to culture: 
a. one 16 year-old boy, was AFB smear negative, but 2 out of 3 cultures were 
positive for Micobacterium abscessus; 
b. one 13 year-old girl, had one positive culture for Micobacterium fortuitum. 
Neither cases could be considered as actively infected according to the ATS criteria. 
Conclusion: Currently, the prevalence of confirmed cases of NTM infection in our 
center is negligible. The regular surveillance for NTM infection of FC patients 
attending our center will make possible to estimate the incidence and the impact 
of this infection on clinical evolution of the disease. In particular, we will evaluate 
the role on airway function, nutritional status and patients' survival. 
• Epidemiology of fungi in culture sputum from Cystic Fibrosis 
patients in Israel 
D. Shoseyov, D. Blum, S. Armoni, E. Kerem. CF Cente~ Hadassah Mt Scopus 
Hospital, Jerusalem, Israel 
Yeasts form and fungi are often found in the respiratory tract secretions of patients 
with cystic fibrosis (CF), although their role for progression of pulmonary disease 
remains unclear. Pervious reports indicated higher prevalence of fungi in autopsies 
of CF patients and it appears to be most closely associated with aggressive 
therapeutic ntervention. Compared with patients with no fungi, those with fungi 
were more frequently treated with indwelling central venous catheters. We have 
previously published that some CF patients may have respiratory exacerbation due 
to Aspergillusfumigatus infection even without he criteria of allergic bronchopul- 
monary aspergillosis (ABPA). These patients improved with antifungal treatment 
and eradication of the aspergillus from the sputum. In order to assess the prevalence 
of fungi in CF patients we collected all culture records of the CF patients in 
4 CF centers in Israel during the years 2002~003. We assessed 769 cultures 
of 256 CF patients. In 521 cultures (68%) the presence of fungi in the sputum 
culture in 23% of the patients. Their average age was 17.48±12.2 years old and 
FEV1 was 67±27% of predicted. Candida lbicans was found in 59% (309) of the 
cultures, candida glabrata 11% (57), aspergillus terreus 8% (41), CPA 7% (35), 
aspergillus fumigatus 7% (35), aspergillus flavum 5% (24), candida tropicalis 
4% (19), aspergillus niger 2% (11), and others that were presented sporadically. 
11% of the sputum presented with 2 fungi. We conclude that the prevalence of fungi 
in the sputum is high and further studies are required to establish its significance. 
